Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer

Conditions:   Pregnancy;   Suspected Deep Vein Thrombosis;   Compression Ultrasound;   D-dimer
Intervention:   Other: LEFt clinical decision rule
Sponsor:   Ottawa Hospital Research Institute
Not yet recruiting - verified July 2015

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Conditions:   Cancer;   Deep-vein Thrombosis of the Lower and Upper Extremities;   Pulmonary Embolism;   Non-valvular Atrial Fibrillation
Intervention:   Other: Retrospective Chart Review
Sponsors:   M.D. Anderson Cancer Center;   Janssen Scientific Affairs, LLC
Not yet recruiting - verified July 2015

Treatment of Saphenous Vein Reflux With 1920-nm Diode Laser

Condition:   Varicose Veins
Interventions:   Device: Endovenous 1920-nm diode laser;   Device: Endovenous 1470-nm diode laser
Sponsor:   Instituto Vascular BH
Completed - verified July 2015

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Conditions:   Aneurysmal Subarachnoid Hemorrhage;   Neurobehavioral Manifestations;   Vasospasm, Intracranial;   Intracranial Aneurysm;   Heparin-induced Thrombocytopenia Type II
Intervention:   Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days)
Sponsors:   Robert F James, MD, FACS, FAANS;   Brain Aneurysm Foundation;   Microvention-Terumo, Inc.;   Penumbra Inc.;   University of Louisville
Not yet recruiting - verified July 2015

Soluble Fibrin for Diagnosing Pulmonary Embolism

Condition:   Pulmonary Embolism (PE)
Intervention:   Other: Soluble Fibrin
Sponsors:   Diagnostica Stago R&D;   European Georges Pompidou Hospital
Recruiting - verified July 2015

FFP Versus PCC in Intracranial Hemorrhage

Conditions:   Intracranial Hemorrhage, Traumatic;   Intracranial Hemorrhage, Spontaneous
Interventions:   Drug: Four Factor Prothrombin Complex Concentrate;   Biological: Fresh Frozen Plasma
Sponsor:   University of Utah
Recruiting - verified April 2015

Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE

Conditions:   Elderly;   Pulmonary Embolism;   Anticoagulants
Intervention:   Other: 4 blood samples
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified July 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

Conditions:   PICC;   Central Venous Catheter;   Central Line;   Neuro ICU;   Neuroscience ICU;   CVC
Interventions:   Device: peripherally inserted central catheter;   Device: centrally inserted central catheter
Sponsor:   Milton S. Hershey Medical Center
Enrolling by invitation - verified July 2015

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis.

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified July 2015

Cancer Venous Thromboembolism (VTE)

Conditions:   Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Cancer
Interventions:   Drug: edoxaban;   Drug: Dalteparin
Sponsor:   Daiichi Sankyo Inc.
Recruiting - verified July 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified July 2015

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Conditions:   Rivaroxaban;   Cancer-associated Thrombosis;   Recurrence;   Bleeding
Intervention:   Drug: Rivaroxaban
Sponsors:   Seoul National University Hospital;   Korean Society of Hematology Thrombosis Working Party
Recruiting - verified July 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified July 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified July 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified July 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified July 2015

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

Conditions:   Vascular Death;   Myocardial Infarction;   Stroke;   Cardiac Surgery
Intervention:  
Sponsors:   Population Health Research Institute;   Abbott Diagnostics Division
Recruiting - verified July 2015

Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein Thrombosis

Conditions:   Venous Thrombosis;   Postthrombotic Syndrome
Interventions:   Procedure: CDT+US group;   Procedure: CDT-US group
Sponsor:   University Hospital Inselspital, Berne
Completed - verified July 2015

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Condition:   Pulmonary Embolism
Intervention:   Device: Denali inferior vena cava filter
Sponsor:   C. R. Bard
Active, not recruiting - verified July 2015

Erythropoietin in Traumatic Brain Injury (EPO-TBI)

Condition:   Traumatic Brain Injury
Intervention:   Drug: Epoetin Alfa
Sponsors:   Australian and New Zealand Intensive Care Research Centre;   National Health and Medical Research Council, Australia;   Australian and New Zealand Intensive Care Society Clinical Trials Group;   Monash University
Completed - verified July 2015

Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures (The HEALTH Study)

Conditions:   Hip Fractures;   Femoral Neck Fractures
Interventions:   Device: Total hip arthroplasty;   Device: Hemi-arthroplasty
Sponsors:   Boston University;   Canadian Institutes of Health Research  (CIHR);   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   Hamilton Health Sciences Corporation;   ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting - verified July 2015

Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma

Conditions:   DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions:   Drug: Clarithromycin;   Drug: Dexamethasone;   Drug: Lenalidomide
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
Active, not recruiting - verified July 2015

Get CardioSmart

You're Invited